These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21178355)

  • 41. Methadone maintenance treatment: a protective factor for cocaine injection in a street-recruited cohort of heroin users.
    Bravo MJ; Llorens N; Barrio G; Brugal MT; Santos S; Sordo L; de la Fuente L;
    Drug Alcohol Depend; 2010 Nov; 112(1-2):62-8. PubMed ID: 20591582
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Psychiatric comorbidity and additional abuse of drugs in maintenance treatment with L- and D,L-methadone.
    Wedekind D; Jacobs S; Karg I; Luedecke C; Schneider U; Cimander K; Baumann P; Ruether E; Poser W; Havemann-Reinecke U
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):390-9. PubMed ID: 20218800
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Remission of psychiatric symptoms among drug misusers after drug dependence treatment.
    Gossop M; Marsden J; Stewart D
    J Nerv Ment Dis; 2006 Nov; 194(11):826-32. PubMed ID: 17102706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is heroin-assisted treatment effective for patients with no previous maintenance treatment? Results from a German randomised controlled trial.
    Haasen C; Verthein U; Eiroa-Orosa FJ; Schäfer I; Reimer J
    Eur Addict Res; 2010; 16(3):124-30. PubMed ID: 20424456
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Opioid addicts at admission vs. slow-release oral morphine, methadone, and sublingual buprenorphine maintenance treatment participants.
    Giacomuzzi S; Kemmler G; Ertl M; Riemer Y
    Subst Use Misuse; 2006; 41(2):223-44. PubMed ID: 16393744
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Does pregnancy affect outcome of methadone maintenance treatment?
    Crandall C; Crosby RD; Carlson GA
    J Subst Abuse Treat; 2004 Jun; 26(4):295-303. PubMed ID: 15182894
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Substance use and response to psychiatric treatment in methadone-treated outpatients with comorbid psychiatric disorder.
    Kidorf M; King VL; Peirce J; Gandotra N; Ghazarian S; Brooner RK
    J Subst Abuse Treat; 2015 Apr; 51():64-9. PubMed ID: 25468006
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Risk of drug-related mortality during periods of transition in methadone maintenance treatment: a cohort study.
    Cousins G; Teljeur C; Motterlini N; McCowan C; Dimitrov BD; Fahey T
    J Subst Abuse Treat; 2011 Oct; 41(3):252-60. PubMed ID: 21696913
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Weight changes of patients in methadone maintenance treatment during four years period].
    Okruhlica Ĺ; Slezáková S
    Cas Lek Cesk; 2012; 151(8):389-91. PubMed ID: 23101891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of lifetime psychiatric diagnosis on long-term retention and survival of former opiate addicts in methadone maintenance treatment.
    Peles E; Schreiber S; Domany Y; Adelson M
    World J Biol Psychiatry; 2014 Dec; 15(8):629-35. PubMed ID: 25140586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Family typology and deterioration related to opioids use, in a methadone treatment patients group].
    Garrido Fernández M; Torrado Val E; Marcos Sierra JA
    Actas Esp Psiquiatr; 2010; 38(4):196-203. PubMed ID: 21104464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Methadone Medical Maintenance: An Early 21st-Century Perspective.
    Novick DM; Salsitz EA; Joseph H; Kreek MJ
    J Addict Dis; 2015; 34(2-3):226-37. PubMed ID: 26110221
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A 12-month evaluation of health-related quality of life outcomes of methadone maintenance program in a rural Malaysian sample.
    Lua PL; Talib NS
    Subst Use Misuse; 2012 Aug; 47(10):1100-5. PubMed ID: 22545914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of treatment retention in a major methadone maintenance treatment program in iran: a survival analysis.
    Pashaei T; Moeeni M; Roshanaei Moghdam B; Heydari H; Turner NE; Razaghi EM
    J Res Health Sci; 2014; 14(4):291-5. PubMed ID: 25503286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. When higher doses in opioid replacement treatment are still inadequate - association to multidimensional illness severity: a cohort study.
    Reimer J; Boniakowski E; Bachner C; Weber B; Tietje W; Verthein U; Walcher S
    Subst Abuse Treat Prev Policy; 2014 Feb; 9():13. PubMed ID: 24581310
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program.
    Pani PP; Trogu E; Contu P; Agus A; Gessa GL
    Drug Alcohol Depend; 1997 Nov; 48(2):119-26. PubMed ID: 9363411
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan.
    Lee HY; Li JH; Wu LT; Wu JS; Yen CF; Tang HP
    Subst Abuse Treat Prev Policy; 2012 Mar; 7():11. PubMed ID: 22429858
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heroin or conventional opioid maintenance? The patients' perspective.
    Bald LK; Bermpohl F; Heinz A; Gallinat J; Gutwinski S
    J Addict Med; 2013; 7(6):401-4. PubMed ID: 24145159
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment.
    Meini M; Moncini M; Daini L; Giarratana T; Scaramelli D; Chericoni S; Stefanelli F; Rucci P
    Eur J Pharmacol; 2015 Aug; 760():1-6. PubMed ID: 25891369
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Leaving methadone maintenance treatment: the role of personality traits and psychiatric status.
    Stenbacka M; Brandt L; Lettholm L
    J Psychoactive Drugs; 2004 Jun; 36(2):227-34. PubMed ID: 15369204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.